Patents by Inventor William Frederick Westlin, III

William Frederick Westlin, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2,4-disubstituted pyrimidines useful as kinase inhibitors
    Patent number: 11351168
    Abstract: The present invention provides 2,4-disubstituted pyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: June 7, 2022
    Assignee: Celgene CAR LLC
    Inventors: Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • Substituted 2,4-diaminopyrimidines as kinase inhibitors
    Patent number: 10828300
    Abstract: The present invention provides 2,4-diaminopyrimidines, and/or pharmaceutically acceptable compositions thereof, as kinase inhibitors.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: November 10, 2020
    Assignee: Celgene CAR LLC
    Inventors: Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • 2,4-disubstituted pyrimidines useful as kinase inhibitors
    Patent number: 10596172
    Abstract: The present invention provides 2,4-disubstituted pyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: March 24, 2020
    Assignee: Celgene CAR LLC
    Inventors: Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20190192512
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: June 29, 2018
    Publication date: June 27, 2019
    Inventors: Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20190117650
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: June 1, 2018
    Publication date: April 25, 2019
    Inventors: Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • 2,4-disubstituted pyrimidines useful as kinase inhibitors
    Patent number: 10010548
    Abstract: The present invention provides 2,4-disubstituted pyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: July 3, 2018
    Assignee: Celgene CAR LLC
    Inventors: Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • Substituted 2,4-diaminopyrimidines as kinase inhibitors
    Patent number: 9987276
    Abstract: The present invention provides 2,4-diaminopyrimidines, and/or pharmaceutically acceptable compositions thereof, as kinase inhibitors.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: June 5, 2018
    Assignee: Celgene CAR LLC
    Inventors: Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • METHODS OF TREATING A BRUTON'S TYROSINE KINASE DISEASE OR DISORDER
    Publication number: 20170173011
    Abstract: The present invention provides methods of treating, stabilizing or lessening the severity or progression of a disease or disorder associated with Bruton's tyrosine kinase (BTK) TEC and interleukin-2-inducible T-cell kinase (ITK).
    Type: Application
    Filed: March 5, 2015
    Publication date: June 22, 2017
    Inventors: William Frederick Westlin, III, Garth Ringheim
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20170100397
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: July 27, 2016
    Publication date: April 13, 2017
    Inventors: Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • Besylate salt of a BTK inhibitor
    Patent number: 9604936
    Abstract: The present invention provides a salt form, and compositions thereof, useful as an inhibitor of one or more protein kinases and which exhibits desirable characteristics for the same.
    Type: Grant
    Filed: October 21, 2013
    Date of Patent: March 28, 2017
    Assignee: Celgene CAR LLC
    Inventors: Steven Richard Witowski, William Frederick Westlin, III, Richland Wayne Tester
  • METHODS OF TREATING A BRUTON'S TYROSINE KINASE DISEASE OR DISORDER
    Publication number: 20160287588
    Abstract: The present invention provides methods of treating, stabilizing or lessening the severity or progression of a disease or disorder associated with BTK.
    Type: Application
    Filed: June 9, 2016
    Publication date: October 6, 2016
    Inventors: Steven Richard Witowski, William Frederick Westlin, III, Heather Lounsbury, Kathryn Stiede, Bruce A. Silver, Jay M. Mei
  • 2,4-disubstituted pyrimidines as kinase inhibitors
    Patent number: 9409921
    Abstract: The present invention provides 2,4-disubstituted pyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: August 9, 2016
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Juswinder Singh, Russell Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • Methods of treating a Bruton's Tyrosine Kinase disease or disorder
    Patent number: 9364476
    Abstract: The present invention provides methods of treating, stabilizing or lessening the severity or progression of a disease or disorder associated with BTK.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: June 14, 2016
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Steven Richard Witowski, William Frederick Westlin, III, Heather Lounsbury, Kathryn Stiede, Bruce A. Silver, Jay M. Mei
  • Substituted 2,4-diaminopyrimidines as kinase inhibitors
    Patent number: 9296737
    Abstract: The present invention provides 2,4-diaminopyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: November 7, 2012
    Date of Patent: March 29, 2016
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • Substituted 2,4-diaminopyrimidines as kinase inhibitors
    Patent number: 9212181
    Abstract: The present invention provides 2,4-diaminopyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: November 7, 2012
    Date of Patent: December 15, 2015
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • METHODS OF TREATING A BRUTON'S TYROSINE KINASE DISEASE OR DISORDER
    Publication number: 20150216865
    Abstract: The present invention provides methods of treating, stabilizing or lessening the severity or progression of a disease or disorder associated with BTK.
    Type: Application
    Filed: September 3, 2013
    Publication date: August 6, 2015
    Inventors: William Frederick Westlin, III, Erica Evans Raab, Zebulun David Horowitz, Claudia Eve Kasserra, Lisa Beebe, Maria Palmisano, Gondi Nagendra Kumar, Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, Deqiang Niu, Lixin Qiao
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20140213574
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: April 16, 2014
    Publication date: July 31, 2014
    Applicant: Celgene Avilomics Research, Inc.
    Inventors: Juswinder Singh, Russell Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • 2,4-disubstituted pyrimidines useful as kinase inhibitors
    Patent number: 8710222
    Abstract: The present invention provides 2,4-disubstituted pyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: April 29, 2014
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Juswinder Singh, Russell Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao
  • BESYLATE SALT OF A BTK INHIBITOR
    Publication number: 20140057929
    Abstract: The present invention provides a salt form, and compositions thereof, useful as an inhibitor of one or more protein kinases and which exhibits desirable characteristics for the same.
    Type: Application
    Filed: October 21, 2013
    Publication date: February 27, 2014
    Applicant: Celgene Avilomics Research, Inc.
    Inventors: Steven Richard Witowski, William Frederick Westlin, III, Richland Wayne Tester
  • 2,4-diaminopyrimidines useful as kinase inhibitors
    Patent number: 8609679
    Abstract: The present invention provides 2,4-diaminopyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: November 7, 2012
    Date of Patent: December 17, 2013
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni, William Frederick Westlin, III, Deqiang Niu, Lixin Qiao